Decoding methylation patterns in ovarian cancer using publicly available Next-Gen sequencing data
暂无分享,去创建一个
Prashant Kumar | Pritish Kumar Varadwaj | Utkarsh Raj | Imlimaong Aier | Prashant Kumar | P. Varadwaj | Utkarsh Raj | Imlimaong Aier
[1] R. Bast,et al. The CA 125 tumour-associated antigen: a review of the literature. , 1989, Human reproduction.
[2] A. Bird,et al. Methylation-Induced Repression— Belts, Braces, and Chromatin , 1999, Cell.
[3] M. Zannini,et al. The Interaction between the Forkhead Thyroid Transcription Factor TTF-2 and the Constitutive Factor CTF/NF-1 Is Required for Efficient Hormonal Regulation of the Thyroperoxidase Gene Transcription* , 1999, The Journal of Biological Chemistry.
[4] Chun-Fang Xu,et al. Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics , 1999, Oncogene.
[5] J. Herman,et al. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. , 2000, Journal of the National Cancer Institute.
[6] J. Inazawa,et al. Identification and characterization of human PKNOX2, a novel homeobox-containing gene. , 2001, Biochemical and biophysical research communications.
[7] C. Plass,et al. Methylation matters , 2001, Journal of medical genetics.
[8] P. Shannon,et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.
[9] J. Herman,et al. Gene silencing in cancer in association with promoter hypermethylation. , 2003, The New England journal of medicine.
[10] A. Jemal,et al. Cancer Statistics, 2005 , 2005, CA: a cancer journal for clinicians.
[11] Peter A. Jones,et al. Epigenetic therapy of cancer: past, present and future , 2006, Nature Reviews Drug Discovery.
[12] S. Baylin,et al. Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction? , 2006, Nature Reviews Cancer.
[13] Michael Weber,et al. Genomic patterns of DNA methylation: targets and function of an epigenetic mark. , 2007, Current opinion in cell biology.
[14] Philippe Broët,et al. HER2 Status in Ovarian Carcinomas: A Multicenter GINECO Study of 320 Patients , 2007, PloS one.
[15] M. Busslinger,et al. Pax5: the guardian of B cell identity and function , 2007, Nature Immunology.
[16] A. Mortazavi,et al. Genome-Wide Mapping of in Vivo Protein-DNA Interactions , 2007, Science.
[17] M. Esteller. Epigenetics in cancer. , 2008, The New England journal of medicine.
[18] Clifford A. Meyer,et al. Model-based Analysis of ChIP-Seq (MACS) , 2008, Genome Biology.
[19] Giovanni Scardoni,et al. Analyzing biological network parameters with CentiScaPe , 2009, Bioinform..
[20] D. Scholtens,et al. Differential methylation profile of ovarian cancer in tissues and plasma. , 2009, The Journal of molecular diagnostics : JMD.
[21] M. Birrer,et al. Prognostic relevance of c-MYC gene amplification and polysomy for chromosome 8 in suboptimally-resected, advanced stage epithelial ovarian cancers: a Gynecologic Oncology Group study. , 2009, Gynecologic oncology.
[22] Sven Mahner,et al. Expression of Jun and Fos proteins in ovarian tumors of different malignant potential and in ovarian cancer cell lines. , 2009, Oncology reports.
[23] T. Ushijima,et al. Aberrant DNA methylation in contrast with mutations , 2010, Cancer science.
[24] Chen Chen,et al. Smad4 mediates malignant behaviors of human ovarian carcinoma cell through the effect on expressions of E-cadherin, plasminogen activator inhibitor-1 and VEGF. , 2010, BMB reports.
[25] Yu Zhang,et al. A Generalized Linear Model for Peak Calling in ChIP-Seq Data , 2012, J. Comput. Biol..
[26] C. Rancourt,et al. Ovarian cancer ascites increase Mcl-1 expression in tumor cells through ERK1/2-Elk-1 signaling to attenuate TRAIL-induced apoptosis , 2012, Molecular Cancer.
[27] Steven L Salzberg,et al. Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.
[28] Hua Zhao,et al. Common variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane-based chemotherapy: a Gynecologic Oncology Group study. , 2012, Gynecologic oncology.
[29] Jie Zhang,et al. Practical Guidelines for the Comprehensive Analysis of ChIP-seq Data , 2013, PLoS Comput. Biol..
[30] Samuel C. Mok,et al. PAX2 Expression in Ovarian Cancer , 2013, International journal of molecular sciences.
[31] H. Fan,et al. YAP Promotes Ovarian Cancer Cell Tumorigenesis and Is Indicative of a Poor Prognosis for Ovarian Cancer Patients , 2014, PloS one.
[32] D. Spandidos,et al. DNA methylation profiles in ovarian cancer: Implication in diagnosis and therapy (Review) , 2014, Molecular medicine reports.
[33] Kamal Raj Pardasani,et al. One Dimensional Finite Element Model to Study Calcium Distribution in Oocytes in Presence of VGCC, RyR and Buffers , 2015 .
[34] Ji-Ying Song,et al. Transcription Factor NFIB Is a Driver of Small Cell Lung Cancer Progression in Mice and Marks Metastatic Disease in Patients , 2016, Cell reports.
[35] Su In Lee,et al. FOXP1 functions as an oncogene in promoting cancer stem cell-like characteristics in ovarian cancer cells , 2015, Oncotarget.
[36] Pritish Kumar Varadwaj,et al. Exploring dual inhibitors for STAT1 and STAT5 receptors utilizing virtual screening and dynamics simulation validation , 2016, Journal of biomolecular structure & dynamics.
[37] Kamal Raj Pardasani,et al. Finite element model to study calcium distribution in oocytes involving voltage gated Ca2+ channel, ryanodine receptor and buffers , 2016 .
[38] D. Otteson,et al. Novel Roles and Mechanism for Krüppel-like Factor 16 (KLF16) Regulation of Neurite Outgrowth and Ephrin Receptor A5 (EphA5) Expression in Retinal Ganglion Cells* , 2016, The Journal of Biological Chemistry.
[39] John Quackenbush,et al. Epigenetic remodeling regulates transcriptional changes between ovarian cancer and benign precursors. , 2016, JCI insight.
[40] Klaus Hansen,et al. An interactive environment for agile analysis and visualization of ChIP-sequencing data , 2016, Nature Structural &Molecular Biology.
[41] Rahul Semwal,et al. Identification of novel dysregulated key genes in Breast cancer through high throughput ChIP-Seq data analysis , 2017, Scientific Reports.
[42] Pritish Kumar Varadwaj,et al. Epigenetics and Its Role in Human Cancer , 2017 .
[43] Samuel C. Mok,et al. ELF3 is a negative regulator of epithelial-mesenchymal transition in ovarian cancer cells , 2017, Oncotarget.
[44] Kamal Raj Pardasani,et al. Three-Dimensional Finite Element Model to Study Effect of RyR Calcium Channel, ER Leak and SERCA Pump on Calcium Distribution in Oocyte Cell , 2018, International Journal of Computational Methods.
[45] Kamal Raj Pardasani,et al. Finite Element Model to Study Calcium Distribution in T Lymphocyte Involving Buffers and Ryanodine Receptors , 2018 .